智通财经APP获悉，香港联交所最新资料显示，8月7日，君圣泰医药-B(02511)出现仓位异动，存仓市值总计2.87亿港元，占比14.73%。该公司股东将股票存入中信证券经纪香港5260.1万股，持股比例增加5.57%。
君圣泰医药截至2025年12月31日止年度业绩显示，该集团取得其他收入1900.7万元，同比减少72.04%；公司拥有人应占亏损2.45亿元，同比减少35.84%；每股亏损0.51元。
智通财经APP获悉，香港联交所最新资料显示，8月7日，君圣泰医药-B(02511)出现仓位异动，存仓市值总计2.87亿港元，占比14.73%。该公司股东将股票存入中信证券经纪香港5260.1万股，持股比例增加5.57%。
君圣泰医药截至2025年12月31日止年度业绩显示，该集团取得其他收入1900.7万元，同比减少72.04%；公司拥有人应占亏损2.45亿元，同比减少35.84%；每股亏损0.51元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.